Notes in Endometrial cancer

To Subscribe, use this Key

Status	Last Update	Fields
Published	02/18/2024	FRS \| Endometrial \| 1.1 \| Anatomy \| Describe the anatomy of the uterus
Published	02/18/2024	FRS \| Endometrial \| 1.2 \| Epidemiology
Published	02/18/2024	FRS \| Endometrial \| 1.3 \| Type 1 vs. type 2 endometrial cancer \| Create a table to compare the epidemiology, risk factors, biologic behaviour, macrosc…
Published	02/18/2024	FRS \| Endometrial \| 1.4 Risk factors
Published	02/18/2024	FRS \| Endometrial \| 1.5.1 \| Pathologic classification of uterine neoplasia
Published	02/18/2024	FRS \| Endometrial \| 1.6.1 \| Endometrioid adenocarcinoma \| Epidemiology, RFs, prognosis
Published	02/18/2024	FRS \| Endometrial \| 1.6.2 \| Endometrioid adenocarcinoma \| Precursor lesion: Endometrial hyperplasia (type I)
Published	02/18/2024	FRS \| Endometrial \| 1.6.3 \| Endometrioid adenocarcinoma \| Macroscopic and microscopic appearance, grading and IHC
Published	02/18/2024	FRS \| Endometrial \| 1.8 \| Clear cell carcinoma / adenocarcinoma (CCC)
Published	02/18/2024	FRS \| Endometrial \| 1.7 \| Uterine serous papillary carcinoma (USPC)
Published	02/18/2024	FRS \| Endometrial \| 2.1 \| Clincal presentation
Published	02/18/2024	FRS \| Endometrial \| 2.2 \| Natural history
Published	02/18/2024	FRS \| Endometrial \| 2.3 \| Workup
Published	02/18/2024	FRS \| Endometrial \| 2.4.1 \| Staging \| Carcinoma \| Describe the 2023 FIGO staging for endometrial carcinoma
Published	02/18/2024	FRS \| Endometrial \| 2.4.2 \| Staging \| Carcinoma \| Compare the 1988 and 2009 FIGO staging systems for uterine carcinoma
Published	02/18/2024	FRS \| Endometrial \| 2.5 \| Prognostic factors
Published	02/18/2024	FRS \| Endometrial \| 2.6 \| Cowden syndrome (aka PTEN Hamartoma Tumour Syndrome)
Published	02/18/2024	FRS \| Endometrial \| 2.7 \| Lynch syndrome
Published	02/18/2024	FRS \| Endometrial \| 3.1 \| Management \| Overview
Published	02/18/2024	FRS \| Endometrial \| 5.2 \| Adjuvant \| Early stage \| Intermediate risk \| Overview
Published	02/18/2024	FRS \| Endometrial \| 5.3 \| Adjuvant \| Early stage \| High-intermediate risk \| Overview
Published	02/18/2024	FRS \| Endometrial \| 5.4 \| Adjuvant \| Early stage \| High risk \| Overview
Published	02/18/2024	FRS \| Endometrial \| 5.5 \| Adjuvant \| Advanced disease \| Overview
Published	02/18/2024	FRS \| Endometrial \| 6 \| Metastatic disease (stage IVB)
Published	02/18/2024	FRS \| Endometrial \| 7 \| Recurrent disease
Published	02/18/2024	FRS \| Endometrial \| 1.6.4 \| Adenocarcinoma \| Differentiation between cervix adenocarcinoma vs. cervical involvement by endometrial adenocarcinoma
Published	02/18/2024	FRS \| Endometrial \| 4.1.1 \| Principles of surgery \| Resection of primary
Published	02/18/2024	FRS \| Endometrial \| 4.1.2 \| Principles of surgery \| SLNBx and Pelvic / PA nodal dissection
Published	02/18/2024	FRS \| Endometrial \| 5.3.1 \| Adjuvant \| Early stage \| Evidence \| List the key adjuvant trials
Published	02/18/2024	FRS \| Endometrial \| 5.3.2 \| Adjuvant \| Early stage \| Stage I, all-comers \| Evidence \| Norwegian trial (Aalders et al.; Obst Gyn 1980)
Published	02/18/2024	FRS \| Endometrial \| 5.3.4 \| Adjuvant \| Early stage \| High-intermediate risk \| Evidence \| GOG 99 (Keys Gyn Onc 2004)
Published	02/18/2024	FRS \| Endometrial \| 5.3.3 \| Adjuvant \| Early stage \| Intermediate risk \| Evidence \| PORTEC-1 (Creutzberg et al. Lancet 2000)
Published	02/18/2024	FRS \| Endometrial \| 5.3.7 \| Adjuvant \| Early stage \| High-intermediate risk \| Evidence \| PORTEC-2 (Nout et al. Lancet 2010; 375: 816–23)
Published	02/18/2024	FRS \| Endometrial \| 5.4.6 \| Adjuvant \| Early stage \| High risk (+some intermediate) \| Evidence \| ASTEC Lancet 2009
Published	02/18/2024	FRS \| Endometrial \| 5.1.1 \| Adjuvant \| Early stage \| Low risk \| Evidence \| First Swedish trial (Sorbe et al IJCG 2009)
Published	02/18/2024	FRS \| Endometrial \| 5.3.6 \| Adjuvant \| Early stage \| High-intermediate risk \| Evidence \| Second Swedish trial (Sorbe et al IGCS 2012)
Published	02/18/2024	FRS \| Endometrial \| 5.1 \| Adjuvant \| Early stage \| Low risk \| Overview
Published	02/18/2024	FRS \| Endometrial \| 3.2 \| Prognosis by stage
Published	02/18/2024	FRS \| Endometrial \| 4.2 \| Medically inoperable
Published	02/18/2024	FRS \| Endometrial \| 5.4.1 \| Adjuvant \| Early stage \| High risk (+ stage III) \| Evidence \| PORTEC-3 (De Boer et al. Lancet Oncol 2018)
Published	02/18/2024	FRS \| Endometrial \| 5.4.2 \| Adjuvant \| Early stage \| High risk (+ high-intermediate risk) \| Evidence \| GOG249 (Randall JCO 2019)
Published	02/18/2024	FRS \| Endometrial \| 5.4.3 \| Adjuvant \| Early stage \| High risk (+ stage III) \| Italian trial Maggi et al. (Br J Cancer, 2006)
Published	02/18/2024	FRS \| Endometrial \| 5.4.4 \| Adjuvant \| Early stage \| High risk \| GOG34 (Morrow, Gyn Oncol 1990)
Published	02/18/2024	FRS \| Endometrial \| 5.4.5 \| Adjuvant \| Early stage \| High risk \| Finnish RCT (Kuoppala, Gyn Onc 2008)
Published	02/18/2024	FRS \| Endometrial \| 5.5.1 \| Adjuvant \| Stage III \| Concurrent chemoRT \| RTOG 9708 (single arm phase II)
Published	02/18/2024	FRS \| Endometrial \| 5.5.3 \| Adjuvant \| Advanced \| Sequential chemoRT \| MaNGO ILIADE-III and NSGO-EC-9501/EORTC-55991 (Swedish, Hogber, Eu J Cance…
Published	02/18/2024	FRS \| Endometrial \| 5.5.2 \| Adjuvant \| Advanced (st III-IV) \| Chemo vs. RT \| GOG 122 (JCO 2006)
Published	02/18/2024	FRS \| Endometrial \| 5.5.5 \| Adjuvant \| Advanced stage (st III-IV) \| Chemo vs. RT \| Cochrane MA Galaal 2014
Published	02/18/2024	FRS \| Endometrial \| 5.5.3 \| Adjuvant \| Advanced (st III-IVA) \| Chemo vs. RT \| GOG 258 (NEJM 2019)
Published	02/18/2024	FRS \| Endometrial \| 5.4.7 \| Adjuvant \| Serous \| Sandwich sequential chemoRT \| Einstein 2012 (phase II single-arm)
Published	02/18/2024	FRS \| Endometrial \| 7.1 \| Relapsed / recurrent disease
Published	02/18/2024	FRS \| Endometrial \| 5.3.8 \| Adjuvant \| Stage I \| Kong MA Cochrane J Natl Cancer Inst 2012
Published	02/18/2024	FRS \| Endometrial \| 8.1 \| RT technique \| Adjuvant EBRT
Published	02/18/2024	FRS \| Endometrial \| 8.2 \| RT technique \| Vaginal vault brachytherapy
Published	02/18/2024	FRS \| Endometrial \| 1.6.4 \| FIGO grading of endometrioid adenocaricnoma
Published	02/18/2024	FRS \| Endometrial \| 8.3 \| Ongoing trials \| PORTEC 4a
Published	02/18/2024	FRS \| Endometrial \| 2.2.2 \| Prognosis
Status	Last Update	Fields